AMPH Historical Earnings image   This AMPH historical earnings page last updated 8/10/2022
AMPH Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/8/20220.12B
Q1 20225/9/20220.12B
Q4 20213/10/20220.12B
Q3 202111/8/20210.11B
Q2 20218/9/20210.10B
Q1 20215/6/20210.10B
Q4 20203/15/20210.10B
Q3 202011/6/20200.08B
Q2 20208/6/20200.09B
Q1 20205/7/20200.08B
Q4 20193/12/20200.08B
Q3 201911/7/20190.08B
Q2 20198/7/20190.08B
Q1 20195/9/20190.08B
Q4 20183/12/201989.69M
Q3 201811/8/201875.54M
Q2 20188/8/201871.04M
Q1 20185/9/201858.39M
Q4 20173/12/201860.40M
Q3 201711/8/201757.92M
Q2 20178/9/201765.19M
Q1 20175/8/201756.67M
Q4 20163/13/201763.54M
Q3 201611/8/201664.22M
Q2 20168/8/201668.03M
Q1 20165/9/201659.37M
Q4 20153/14/201676.91M
Q3 201511/12/201563.87M
Q2 20158/12/201553.85M
Q1 20155/13/201556.89M
Q4 20143/24/201555.88M
Q3 201411/12/201459.70M
Q2 20148/12/201449.00M
AMPH Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20228/8/20220.390
Q1 20225/9/20220.470
Q4 20213/10/20220.420
Q3 202111/8/20210.460
Q2 20218/9/20210.210
Q1 20215/6/20210.270
Q4 20203/15/20210.160
Q3 202011/6/20200.150
Q2 20208/6/20200.160
Q1 20205/7/20200.170
Q4 20193/12/20200.070
Q3 201911/7/20190.100
Q2 20198/7/20190.080
Q1 20195/9/20190.100
Q4 20183/12/20190.13
Q3 201811/8/20180.12
Q2 20188/8/20180.03
Q1 20185/9/2018-0.05
Q4 20173/12/20180.1
Q3 201711/8/20170.07
Q2 20178/9/20170.11
Q1 20175/8/20170.09
Q4 20163/13/20170.01
Q3 201611/8/20160.14
Q2 20168/8/20160.23
Q1 20165/9/20160.12
Q4 20153/14/20160.19
Q3 201511/12/2015-0.01
Q2 20158/12/2015-0.09
Q1 20155/13/2015-0.01
Q4 20143/24/2015-0.03
Q3 201411/12/2014-0.07
Q2 20148/12/20140.02
Quotes delayed 20 minutes

Email EnvelopeFree AMPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Amphastar Pharmaceuticals (AMPH) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AMRX Historical Earnings
AMTI Historical Earnings
ANAB Historical Earnings
ANGN Historical Earnings
ANGO Historical Earnings
ANIK Historical Earnings
ANIP Historical Earnings
ANIX Historical Earnings
ANNX Historical Earnings
ANVS Historical Earnings
What was the record high AMPH historical earnings result?
In terms of earnings or revenue, what is the best AMPH historical earnings result that Amphastar Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest AMPH historical earnings result was set in Q1 2022, when Amphastar Pharmaceuticals posted results of 0.470/share. The most successful revenue quarter within our data set was Q2 2022 when Amphastar Pharmaceuticals reported revenue of 0.12B.

What was the lowest Amphastar Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest AMPH has reported, and when?

✔️Accepted answer: Within our data set, the lowest AMPH historical earnings result was set in Q2 2015, when Amphastar Pharmaceuticals posted results of -0.09/share. The smallest revenue quarter within our data set was Q2 2014 when Amphastar Pharmaceuticals reported revenue of 49.00M.

On this page we presented the AMPH historical earnings date information for Amphastar Pharmaceuticals. Reviewing that AMPH Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2022, when AMPH posted adjusted EPS of 0.470/share. Meanwhile the lowest AMPH historical earnings result was in Q2 2015, when AMPH posted adjusted EPS of -0.09/share. Moving to Amphastar Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when AMPH reported 0.12B in revenue, while the smallest revenue quarter was Q2 2014 when AMPH reported 49.00M in revenue.

For self directed investors doing their due diligence on AMPH or any other given stock, their research can benefit from looking into all of the Amphastar Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Amphastar Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for AMPH. Thanks for visiting, and the next time you need to research AMPH historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Funds Holding HYBL, LYEL shares outstanding history, ETFs Holding ACRX.

 

AMPH Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.